Literature DB >> 3084924

Interferon-gamma induction in human peripheral blood mononuclear cells by OK-432, a killed preparation of Streptococcus pyogenes.

T Noda, M Asano, O Yoshie, R Suzuki, T Ebina, N Ishida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3084924     DOI： 10.1111/j.1348-0421.1986.tb00923.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN： 0385-5600            Impact factor:   1.955


× No keyword cloud information.
  6 in total

1.  Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Gamma interferon is produced by human natural killer cells but not T cells during Staphylococcus aureus stimulation.

Authors:  R Yoshihara; S Shiozawa; T Fujita; K Chihara
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

3.  Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.

Authors:  M Katano; H Yamamoto; T Mizoguchi; T Hisatsugu
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; H Tanimura; M Iwahashi; M Tani; T Tsunoda; K Tabuse; K Kuribayashi; K Saito
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).

Authors:  M Katano; T Mizoguchi; H Yamamoto; M Nakamura; T Matsuo; T Hisatugu; T Kisu; K Yamaoka; O Tokunaga
Journal:  Jpn J Surg       Date:  1990-01

6.  The changing pattern of the splenic lymphocyte subsets in tumor-bearing mice after oral treatment with OK-432.

Authors:  Y Akamatsu; S Fuchimoto; K Orita
Journal:  Jpn J Cancer Res       Date:  1992-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.